An approach to the management of chronic myeloid leukemia in British Columbia.
about
A novel AHI-1-BCR-ABL-DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated autophagy.AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders.Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylateTargeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex.Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cells.
P2860
An approach to the management of chronic myeloid leukemia in British Columbia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
An approach to the management of chronic myeloid leukemia in British Columbia.
@ast
An approach to the management of chronic myeloid leukemia in British Columbia.
@en
type
label
An approach to the management of chronic myeloid leukemia in British Columbia.
@ast
An approach to the management of chronic myeloid leukemia in British Columbia.
@en
prefLabel
An approach to the management of chronic myeloid leukemia in British Columbia.
@ast
An approach to the management of chronic myeloid leukemia in British Columbia.
@en
P2093
P2860
P356
P1433
P1476
An approach to the management of chronic myeloid leukemia in British Columbia.
@en
P2093
P2860
P356
10.3747/CO.V15I2.224
P577
2008-04-01T00:00:00Z